Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2019

16.05.2019 | Epidemiology

Effects of tea consumption and the interactions with lipids on breast cancer survival

verfasst von: Jia-Yi Zhang, Yu-Huang Liao, Ying Lin, Qiang Liu, Xiao-Ming Xie, Lu-Ying Tang, Ze-Fang Ren

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The effect of tea consumption on breast cancer survival remained to be explored. Meanwhile, green tea favorably facilitates lipid metabolisms in breast cancer survivors. This study aimed to examine the effect of tea consumption and the interactions with lipids on breast cancer survival.

Methods

A total of 1551 breast cancer patients were recruited between April 2008 and March 2012 and followed up until 31 December 2017 in Guangzhou. The endpoint was progression-free survival (PFS). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using multivariate Cox proportional to estimate the associations.

Results

PFS was better among women who regularly drank all teas (mainly green tea) except oolong after cancer diagnosis compared with non-tea drinkers (HR 0.52; 95% CI 0.29 ~ 0.91). This association was more evident among women with normal (HR 0.38; 95% CI 0.18 ~ 0.82) than higher (HR 1.22; 95% CI 0.13 ~ 11.82) total cholesterol, though the interaction was not significant. Moreover, the more they drank (≥ 7 times/week), the better prognosis was (HR 0.30; 95% CI 0.11 ~ 0.84). In contrast, oolong tea was observed to have a potential impaired effect on PFS.

Conclusions

Our findings suggested that regularly drinking all teas (mainly green tea) except oolong after diagnosis was beneficial to breast cancer survival, particularly for women with normal lipids, while oolong tea may have an impaired effect.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, Bonaventure A, Valkov M, Johnson CJ, Esteve J, Ogunbiyi OJ, Azevedo ESG, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP (2018) Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England) 391(10125):1023–1075. https://doi.org/10.1016/s0140-6736(17)33326-3 CrossRefPubMedCentral Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, Bonaventure A, Valkov M, Johnson CJ, Esteve J, Ogunbiyi OJ, Azevedo ESG, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP (2018) Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England) 391(10125):1023–1075. https://​doi.​org/​10.​1016/​s0140-6736(17)33326-3 CrossRefPubMedCentral
6.
Zurück zum Zitat Yiannakopoulou E (2014) Green tea catechins: proposed mechanisms of action in breast cancer focusing on the interplay between survival and apoptosis. Anti-Cancer Agents Med Chem 14(2):290–295CrossRef Yiannakopoulou E (2014) Green tea catechins: proposed mechanisms of action in breast cancer focusing on the interplay between survival and apoptosis. Anti-Cancer Agents Med Chem 14(2):290–295CrossRef
7.
Zurück zum Zitat Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89(3):254–261CrossRefPubMedPubMedCentral Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89(3):254–261CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Hirose K, Hamajima N, Tominaga S (2001) Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167(2):175–182CrossRefPubMed Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Hirose K, Hamajima N, Tominaga S (2001) Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167(2):175–182CrossRefPubMed
9.
Zurück zum Zitat Velentzis LS, Keshtgar MR, Woodside JV, Leathem AJ, Titcomb A, Perkins KA, Mazurowska M, Anderson V, Wardell K, Cantwell MM (2011) Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study. Breast Cancer Res Treat 128(2):473–482. https://doi.org/10.1007/s10549-010-1238-8 CrossRefPubMed Velentzis LS, Keshtgar MR, Woodside JV, Leathem AJ, Titcomb A, Perkins KA, Mazurowska M, Anderson V, Wardell K, Cantwell MM (2011) Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study. Breast Cancer Res Treat 128(2):473–482. https://​doi.​org/​10.​1007/​s10549-010-1238-8 CrossRefPubMed
13.
Zurück zum Zitat Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, Hsieh CC (1999) Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Urology 54(5):823–828CrossRefPubMed Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, Hsieh CC (1999) Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Urology 54(5):823–828CrossRefPubMed
15.
Zurück zum Zitat Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, Lippman SM, Hershman DL (2015) Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. J Hum Nutr Diet 28(3):272–282. https://doi.org/10.1111/jhn.12229 CrossRefPubMed Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, Lippman SM, Hershman DL (2015) Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. J Hum Nutr Diet 28(3):272–282. https://​doi.​org/​10.​1111/​jhn.​12229 CrossRefPubMed
17.
Zurück zum Zitat Tornberg S, Carstensen J (1993) Serum beta-lipoprotein, serum cholesterol and Quetelet’s index as predictors for survival of breast cancer patients. Eur J Cancer (Oxford, England: 1990) 29a(14):2025–2030CrossRef Tornberg S, Carstensen J (1993) Serum beta-lipoprotein, serum cholesterol and Quetelet’s index as predictors for survival of breast cancer patients. Eur J Cancer (Oxford, England: 1990) 29a(14):2025–2030CrossRef
26.
Zurück zum Zitat Tartter PI, Papatestas AE, Ioannovich J, Mulvihill MN, Lesnick G, Aufses AH Jr (1981) Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47(9):2222–2227CrossRefPubMed Tartter PI, Papatestas AE, Ioannovich J, Mulvihill MN, Lesnick G, Aufses AH Jr (1981) Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47(9):2222–2227CrossRefPubMed
29.
30.
38.
Zurück zum Zitat Xu X, Cai L (2013) A case-control study on tea consumption and the risk of lung cancer. Wei sheng yan jiu = J Hyg Res 42(2):211–216 Xu X, Cai L (2013) A case-control study on tea consumption and the risk of lung cancer. Wei sheng yan jiu = J Hyg Res 42(2):211–216
39.
Zurück zum Zitat Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A (2011) Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 65(3):230–240. https://doi.org/10.1136/jech.2009.097311 CrossRefPubMed Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A (2011) Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 65(3):230–240. https://​doi.​org/​10.​1136/​jech.​2009.​097311 CrossRefPubMed
Metadaten
Titel
Effects of tea consumption and the interactions with lipids on breast cancer survival
verfasst von
Jia-Yi Zhang
Yu-Huang Liao
Ying Lin
Qiang Liu
Xiao-Ming Xie
Lu-Ying Tang
Ze-Fang Ren
Publikationsdatum
16.05.2019
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2019
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05253-5

Weitere Artikel der Ausgabe 3/2019

Breast Cancer Research and Treatment 3/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.